Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

Authors

Keywords

Journal

Volume 15, Issue 12, Pages 1389-1396

Publisher

Elsevier BV

Online

2014-10-16

DOI

10.1016/s1470-2045(14)70473-5

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now